Michael J Pontecorvo

Summary

Publications

  1. doi request reprint Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
    Michael J Pontecorvo
    Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company, 3711 Market St, Philadelphia, PA, 19104, USA
    Eur J Nucl Med Mol Imaging . 2017
  2. pmc Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, Philadelphia, PA 19104, USA
    Brain . 2017
  3. pmc PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders
    Andrew Siderowf
    Banner Sun Health Research Institute, Sun City, AZ 10515W Santa Fe Dr, USA
    BMC Neurol 14:79. 2014
  4. pmc PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    Alzheimers Res Ther 3:11. 2011
  5. doi request reprint Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, Philadelphia, PA 19104, USA
    J Nucl Med 53:378-84. 2012
  6. ncbi request reprint Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, PA, USA
    Lancet Neurol 11:669-78. 2012
  7. pmc Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
    David A Wolk
    Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
    J Neurol Neurosurg Psychiatry 83:923-6. 2012
  8. pmc Radiation dosimetry of florbetapir F 18
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    EJNMMI Res 4:4. 2014
  9. doi request reprint A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, Philadelphia, Pennsylvania
    J Nucl Med 56:1736-41. 2015
  10. doi request reprint Use of florbetapir-PET for imaging beta-amyloid pathology
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA
    JAMA 305:275-83. 2011

Detail Information

Publications11

  1. doi request reprint Quantitation of PET signal as an adjunct to visual interpretation of florbetapir imaging
    Michael J Pontecorvo
    Avid Radiopharmaceuticals a wholly owned subsidiary of Eli Lilly and Company, 3711 Market St, Philadelphia, PA, 19104, USA
    Eur J Nucl Med Mol Imaging . 2017
    ..This study examined the feasibility of using quantitation to augment interpretation of florbetapir PET amyloid imaging...
  2. pmc Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, Philadelphia, PA 19104, USA
    Brain . 2017
    ..Further, the results are consistent with the hypothesis that cortical tau is associated with cognitive impairment...
  3. pmc PET imaging of amyloid with Florbetapir F 18 and PET imaging of dopamine degeneration with 18F-AV-133 (florbenazine) in patients with Alzheimer's disease and Lewy body disorders
    Andrew Siderowf
    Banner Sun Health Research Institute, Sun City, AZ 10515W Santa Fe Dr, USA
    BMC Neurol 14:79. 2014
    ....
  4. pmc PET amyloid imaging as a tool for early diagnosis and identifying patients at risk for progression to Alzheimer's disease
    Michael J Pontecorvo
    Avid Radiopharmaceuticals, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    Alzheimers Res Ther 3:11. 2011
    ..Although large longitudinal studies like the ongoing ADNI trial will be required for definitive evaluation, present data suggest that PET amyloid imaging has the potential to promote earlier and more specific diagnosis of dementia...
  5. doi request reprint Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, Philadelphia, PA 19104, USA
    J Nucl Med 53:378-84. 2012
    ..In a separate set of subjects (AD, n = 10; YHCs, n = 10), test-retest reliability was evaluated by comparing intrasubject visual read ratings and SUVrs for 2 PET images acquired within 4 wk of each other...
  6. ncbi request reprint Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, PA, USA
    Lancet Neurol 11:669-78. 2012
    ..We therefore prospectively compared the sensitivity and specificity of amyloid PET imaging with neuropathology at autopsy...
  7. pmc Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography
    David A Wolk
    Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA
    J Neurol Neurosurg Psychiatry 83:923-6. 2012
    ..Florbetapir-F18 recently demonstrated in vivo correlation with postmortem Aβ histopathology, but has not been directly compared with PiB-C11...
  8. pmc Radiation dosimetry of florbetapir F 18
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, 3711 Market Street, 7th Floor, Philadelphia, PA 19104, USA
    EJNMMI Res 4:4. 2014
    ..As the bio-distribution and radiation dose of PET tracers in human research are important for estimating the relative risks and benefits, a study was conducted to obtain this information on florbetapir...
  9. doi request reprint A Semiautomated Method for Quantification of F 18 Florbetapir PET Images
    Abhinay D Joshi
    Avid Radiopharmaceuticals, Inc, Philadelphia, Pennsylvania
    J Nucl Med 56:1736-41. 2015
    ....
  10. doi request reprint Use of florbetapir-PET for imaging beta-amyloid pathology
    Christopher M Clark
    Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA
    JAMA 305:275-83. 2011
    ..The ability to identify and quantify brain β-amyloid could increase the accuracy of a clinical diagnosis of Alzheimer disease...
  11. doi request reprint Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent
    John Lister-James
    Avid Radiopharmaceuticals, Philadelphia, PA
    Semin Nucl Med 41:300-4. 2011
    ..Clinical studies have demonstrated a clear correlation between in vivo PET imaging with florbetapir F-18 and postmortem histopathologic quantitation of β-amyloid in the brain...